It was already demonstrated in 2004 that administration of TSA to BC cells resistant to tamoxifen caused an increase in estrogen receptor expression, which in turn allowed for re-sensitization of these cells to the administered drug [49]. This evidence concerns the gene ESR1 and breast cancer.